China Shineway Pharmaceutical

China Shineway Pharmaceutical, a Pharmaceutical Preparation Manufacturing company headquartered in CN, does not have its own directly reported emissions data available for the most recent years. Instead, its emissions data is cascaded from its parent company, China Shineway Pharmaceutical Group Limited.

For 2021, China Shineway Pharmaceutical Group Limited reported total emissions of approximately 117,794,000 kg CO2e. This included Scope 1 emissions of approximately 76,087,000 kg CO2e, Scope 2 emissions of approximately 16,885,000 kg CO2e, and Scope 3 emissions of approximately 24,822,000 kg CO2e.

Looking back, the cascaded total emissions from China Shineway Pharmaceutical Group Limited were:

• 2020: Approximately 130,989,000 kg CO2e, comprising Scope 1 emissions of around 100,252,000 kg CO2e, Scope 2 emissions of about 7,391,000 kg CO2e, and Scope 3 emissions of approximately 23,345,000 kg CO2e.
• 2019: Approximately 145,136,000 kg CO2e, with Scope 1 emissions around 111,082,000 kg CO2e, Scope 2 emissions about 9,492,000 kg CO2e, and Scope 3 emissions of approximately 24,561,000 kg CO2e.
• 2018: Approximately 145,465,000 kg CO2e, including Scope 1 emissions of about 108,236,000 kg CO2e, Scope 2 emissions of approximately 13,184,000 kg CO2e, and Scope 3 emissions of about 24,045,000 kg CO2e.
• 2017: Approximately 153,410,000 kg CO2e, with Scope 1 emissions around 117,620,000 kg CO2e, Scope 2 emissions about 8,186,000 kg CO2e, and Scope 3 emissions of approximately 27,604,000 kg CO2e.

No specific reduction targets or climate pledges for China Shineway Pharmaceutical are available in the provided data.